Dr. Reddy's Laboratories Ltd. closed 14.27% below its 52-week high of 1,420.20 rupees, which the company achieved on August ...

Dr. Reddy's Laboratories Ltd. closed 16.92% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

Dr. Reddy’s Laboratories has received an order directing the company to pay more than ₹184 crore penalty under the CGST Act 2017. The authority has passed the order on the contention that the company ...

Discover the Dr Reddys Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Stay updated with the Dr Reddys Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

Q3 2025 Earnings Call Transcript January 23, 2025 Operator: Ladies and gentlemen, good day and welcome to the Quarter Three ...

New Delhi: Pharmaceutical major Dr Reddy's has got approval from the Subject Expert Committee (SEC) functional under the ...

Dr. Reddy's Lab is poised to witness crosswinds from a drop in revenue from the patent expiration of Revlimid and increased ...

Dr Reddy's Laboratories Chairman Satish Reddy hails Union Budget 2025-26 for its focus on nation-building through structural reforms, including investment in technology, infrastructure, and healthcare ...

Union budget 2025-26 takes strong steps toward nation-building through structural reforms such as investment in technology and infrastructure, simplification of tax slabs and duties, among ...